Hmmm not sure what to say about this stock right now. The 1 month chart shows lower lows, lower highs. That's usually a bearish move.
My guess is that IMGN is due for a pullback in the short-run. check out awesom_sto-cks, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
MicroCap News Alert: - Startup - Clean Energy Technologies (CETY) buys General Electric “Heat Recovery Systems Division” and within 2 years achieves break-even with sales now set to soar and to be profitable.
CETY announced today the launch of Pacific Rim Initiative with over 20 locations already identified by CETY and PPA power company authorities.
Early orders likely to exceed $25 million in annuitized sales. 12 month target price $.25
CETY/GE proprietary oil-free magnetic levitation turbine technology shatters the competition’s old oil-lubricated screw expander technologies.
Company expects to up list to NASDAQ.
CETY's implementation includes creative lease financing structure, that facilitates rapid adoption and ease of entry with long-term payment structure that allows the utility user to align its investment with actual energy and cost savings realized through use of Clean Cycle™ units," said Kam Mahdi, CEO of CETY.
CETY being welcomed with red carpet to largest markets in the world in need of clean energy.
Clean Energy Technologies (CETY) Launches Pacific Rim Initiative
COSTA MESA, Calif. , Aug. 15, 2017 Clean Energy Technologies, Inc. (OTC: CETY) announced that CETY officially launched its new campaign to deliver its energy solutions to Island Nations utilities at the ...
Uptrend appears unbroken. Stock didn't want to stay down yesterday.
Why is it that most reports about this company are slanted to the negative? Why don't they tout the 6 company owned products and the 16 partnerships? One article stated that they had missed their projections three quarters in a row-fakenews?????
Jefferies Reaffirms Their Buy Rating on ImmunoGen - Analyst Ratings
August 7, 2017 Jefferies analyst Michael Yee reiterated a Buy rating on ImmunoGen (NASDAQ: IMGN) yesterday and set a price target of $9. The company's shares closed on Fr
I am betting this stock won't make it to years end without being bought out. This company has many drugs in various places in the pipeline, it is absolutely a buyout target, and buying with these short attacks is almost too easy, your about to watch this run in my opinion, either way short or long GLTA
United Therapeutics Corp. stock surges 9% on report of possible bids for company
If we are to go off the RSI then you could argue that a pull back next day or so could occur on IMGN before rallying up. Do you guys find it difficult to know when to buy or sell something? I prefer to get my stocks from Awe.Some.Sto-ck.s.